13F

FHTX FOGHORN THERAPEUTICS INC

2026Q1 · CUSIP 344174107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
104
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
60
Δ whales
+5
Inst. holding value
$212M
New positions
22
Closed positions
11
Price momentum (1Q)
-31.3%
Put / Call
0/0

Breadth history (34 quarters)

2021Q1: Δ-2 · h=46 2021Q2: Δ-6 · h=40 2021Q3: Δ+8 · h=48 2021Q4: Δ+12 · h=60 2022Q1: Δ+2 · h=62 2022Q2: Δ+0 · h=62 2022Q3: Δ+1 · h=63 2022Q4: Δ+3 · h=66 2023Q1: Δ-4 · h=62 2023Q2: Δ-2 · h=60 2023Q3: Δ+2 · h=62 2023Q4: Δ-2 · h=60 2024Q1: Δ+10 · h=70 2024Q2: Δ+3 · h=73 2024Q3: Δ+7 · h=80 2024Q4: Δ+8 · h=88 2025Q1: Δ+2 · h=90 2025Q2: Δ-7 · h=83 2025Q3: Δ+6 · h=89 2025Q4: Δ+4 · h=93 2026Q1: Δ+11 · h=104 2021Q1: holders=46 2021Q2: holders=40 2021Q3: holders=48 2021Q4: holders=60 2022Q1: holders=62 2022Q2: holders=62 2022Q3: holders=63 2022Q4: holders=66 2023Q1: holders=62 2023Q2: holders=60 2023Q3: holders=62 2023Q4: holders=60 2024Q1: holders=70 2024Q2: holders=73 2024Q3: holders=80 2024Q4: holders=88 2025Q1: holders=90 2025Q2: holders=83 2025Q3: holders=89 2025Q4: holders=93 2026Q1: holders=104 -12 -6 +0 +6 +12 3673110 21Q121Q322Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.17
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
+20.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $4M 2022-09-30: $7M 2022-12-31: $4M 2023-03-31: $5M 2023-06-30: $6M 2023-09-30: $17M 2023-12-31: $6M 2024-03-31: $5M 2024-06-30: $7M 2024-09-30: $8M 2024-12-31: $3M 2025-03-31: $6M 2025-06-30: $8M 2025-09-30: $8M 2025-12-31: $9M 2026-03-31: $3M 2022-06-30: EPS -0.66 2022-09-30: EPS -0.62 2022-12-31: EPS -0.69 2023-03-31: EPS -0.73 2023-06-30: EPS -0.70 2023-09-30: EPS -0.34 2023-12-31: EPS -0.57 2024-03-31: EPS -0.59 2024-06-30: EPS -0.45 2024-09-30: EPS -0.31 2024-12-31: EPS -0.23 2025-03-31: EPS -0.30 2025-06-30: EPS -0.28 2025-09-30: EPS -0.25 2025-12-31: EPS -0.35 2026-03-31: EPS -0.29 0M 9M 17M $M -0.80 -0.40 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)